Greenhaven Associates
Streaks
1 name has been in this book every quarter on record (53). New in this book this quarter: BDX, ACN, IQV, EPAM.
Over time
Filings
- Q2 2026 filed Jul 28, 26 $8.7B · 28 positions · 4 new · 3 exited full · Concentrated 4 new · 3 exited
- Q1 2026 filed Apr 6, 26 $6.1B · 27 positions · 1 new · 4 exited full · Concentrated 1 new · 4 exited
- Q4 2025 filed Jan 7, 26 $6.2B · 30 positions · 4 new · 1 exited full · Very concentrated 4 new · 1 exited
- Q3 2025 filed Nov 4, 25 $6.6B · 27 positions · 3 new · 1 exited full · Very concentrated 3 new · 1 exited
- Q2 2025 filed Jul 8, 25 $6.7B · 25 positions · 1 new · 2 exited full · Very concentrated 1 new · 2 exited
- Q1 2025 filed Apr 2, 25 $6.3B · 26 positions · 3 new · 1 exited full · Very concentrated 3 new · 1 exited
- Q4 2024 filed Jan 17, 25 $6.8B · 24 positions · 0 new · 0 exited full · Very concentrated 0 new · 0 exited
- Q3 2024 filed Oct 2, 24 $8.5B · 24 positions · 0 new · 1 exited full · Very concentrated 0 new · 1 exited
- Q2 2024 filed Jul 15, 24 $7.6B · 25 positions · 0 new · 2 exited full · Very concentrated 0 new · 2 exited
- Q1 2024 filed Apr 26, 24 $10.9B · 27 positions · 0 new · 0 exited full · Concentrated 0 new · 0 exited
- Q4 2023 filed Jan 9, 24 $9.4B · 27 positions · 1 new · 3 exited full · Concentrated 1 new · 3 exited
- Q3 2023 filed Oct 2, 23 $7.7B · 29 positions · 2 new · 2 exited full · Concentrated 2 new · 2 exited
- Q2 2023 filed Jul 13, 23 $7.5B · 29 positions · 1 new · 4 exited full · Concentrated 1 new · 4 exited
- Q1 2023 filed Apr 4, 23 $6.4B · 32 positions · 2 new · 2 exited full · Concentrated 2 new · 2 exited
- Q4 2022 filed Jan 10, 23 $5.6B · 32 positions · 1 new · 0 exited full · Concentrated 1 new · 0 exited
- Q3 2022 filed Oct 5, 22 $4.8B · 31 positions · 4 new · 0 exited full · Concentrated 4 new · 0 exited
- Q2 2022 filed Aug 1, 22 $4.6B · 27 positions · 5 new · 0 exited full · Concentrated 5 new · 0 exited
- Q1 2022 filed May 4, 22 $3.8B · 22 positions · 2 new · 1 exited full · Very concentrated 2 new · 1 exited
- Q4 2021 filed Jan 18, 22 $4.0B · 21 positions · 3 new · 1 exited full · Very concentrated 3 new · 1 exited
- Q3 2021 filed Oct 11, 21 $3.0B · 19 positions · 0 new · 1 exited full · Very concentrated 0 new · 1 exited
- Q2 2021 filed Aug 2, 21 $3.4B · 20 positions · 0 new · 4 exited full · Very concentrated 0 new · 4 exited
- Q1 2021 filed May 13, 21 $4.4B · 24 positions · 1 new · 5 exited full · Very concentrated 1 new · 5 exited
- Q4 2020 filed Feb 3, 21 $5.3B · 28 positions · 1 new · 1 exited full · Concentrated 1 new · 1 exited
- Q3 2020 filed Oct 23, 20 $4.6B · 28 positions · 1 new · 7 exited full · Concentrated 1 new · 7 exited
- Q2 2020 filed Jul 31, 20 $4.5B · 34 positions · 10 new · 3 exited full · Concentrated 10 new · 3 exited
- Q1 2020 filed May 6, 20 $2.7B · 27 positions · 8 new · 1 exited full · Concentrated 8 new · 1 exited
- Q4 2019 filed Jan 10, 20 $4.5B · 20 positions · 0 new · 2 exited full · Very concentrated 0 new · 2 exited
- Q3 2019 filed Nov 8, 19 $4.9B · 22 positions · 1 new · 4 exited full · Very concentrated 1 new · 4 exited
- Q2 2019 filed Aug 7, 19 $5.7B · 25 positions · 3 new · 2 exited full · Concentrated 3 new · 2 exited
- Q1 2019 filed May 2, 19 $5.6B · 24 positions · 1 new · 0 exited full · Concentrated 1 new · 0 exited
- Q4 2018 filed Jan 14, 18 $5.2B · 23 positions · 0 new · 1 exited mostly · Concentrated 0 new · 1 exited
- Q3 2018 filed Oct 17, 18 $6.5B · 24 positions · 0 new · 0 exited mostly · Concentrated 0 new · 0 exited
- Q2 2018 filed Jul 17, 18 $6.7B · 24 positions · 1 new · 0 exited mostly · Concentrated 1 new · 0 exited
- Q1 2018 filed May 7, 18 $6.4B · 23 positions · 2 new · 2 exited mostly · Concentrated 2 new · 2 exited
- Q4 2017 filed Jan 11, 18 $6.6B · 23 positions · 2 new · 2 exited mostly · Concentrated 2 new · 2 exited
- Q3 2017 filed Oct 25, 17 $6.7B · 23 positions · 0 new · 0 exited mostly · Concentrated 0 new · 0 exited
- Q2 2017 filed Aug 9, 17 $6.6B · 23 positions · 1 new · 3 exited mostly · Concentrated 1 new · 3 exited
- Q1 2017 filed Apr 25, 17 $6.3B · 25 positions · 1 new · 0 exited mostly · Concentrated 1 new · 0 exited
- Q4 2016 filed Jan 23, 17 $5.9B · 24 positions · 2 new · 0 exited full · Concentrated 2 new · 0 exited
- Q3 2016 filed Nov 3, 16 $5.2B · 22 positions · 1 new · 1 exited full · Concentrated 1 new · 1 exited
- Q2 2016 filed Aug 3, 16 $10.2B · 22 positions · 2 new · 4 exited full · Concentrated 2 new · 4 exited
- Q1 2016 filed May 5, 16 $5.2B · 24 positions · 2 new · 2 exited mostly · Concentrated 2 new · 2 exited
- Q4 2015 filed Feb 4, 16 $5.3B · 24 positions · 4 new · 2 exited mostly · Concentrated 4 new · 2 exited
- Q3 2015 filed Oct 13, 15 $5.0B · 22 positions · 0 new · 2 exited full · Concentrated 0 new · 2 exited
- Q2 2015 filed Jul 10, 15 $5.5B · 24 positions · 1 new · 2 exited full · Concentrated 1 new · 2 exited
- Q1 2015 filed May 1, 15 $5.6B · 25 positions · 2 new · 4 exited full · Concentrated 2 new · 4 exited
- Q4 2014 filed Feb 4, 15 $5.6B · 27 positions · 5 new · 4 exited full · Concentrated 5 new · 4 exited
- Q3 2014 filed Oct 30, 14 $5.2B · 26 positions · 3 new · 3 exited full · Concentrated 3 new · 3 exited
- Q2 2014 filed Aug 13, 14 $5.3B · 26 positions · 3 new · 1 exited full · Concentrated 3 new · 1 exited
- Q1 2014 filed Apr 29, 14 $4.9B · 24 positions · 2 new · 2 exited full · Concentrated 2 new · 2 exited
- Q4 2013 filed Jan 13, 14 $4.8B · 24 positions · 8 new · 7 exited full · Concentrated 8 new · 7 exited
- Q3 2013 filed Oct 22, 13 $4.3B · 23 positions · 8 new · 11 exited mostly · Concentrated 8 new · 11 exited
- Q2 2013 filed Aug 1, 13 $3.7B · 26 positions · 0 new · 0 exited full · Concentrated 0 new · 0 exited





